A woman from Hainesport, New Jersey, has filed a products liability lawsuit against GlaxoSmithKline (GSK) alleging that the anti-nausea drug Zofran (generic: ondansetron) caused her daughter to be born with multiple life-threatening birth defects.
Free Confidential Lawsuit Evaluation: If your child or other loved one was born with a birth defect after the mother took Zofran during pregnancy, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the Problem?
August 3, 2016 – According to the lawsuit, Plaintiff suffered from morning sickness and migraine headaches during her first trimester of her pregnancy, and was prescribed Zofran to treat these symptoms. Her daughter, referred to in court documents as “B.B.”, was born on May 13, 2007, and subsequently diagnosed with numerous congenital abnormalities including a pair of heart defects and dysmorphic facial features.
Now 9-years-old, B.B. allegedly suffers from both an atrial septal defect (ASD) and ventricular septal defect (VSD), and continues to struggle with developmental delays which require specialized education services.
Hydronephrosis, a kidney defect that occurs when the kidney swells due to the failure of normal drainage of urine from the kidney to the bladder, is also alleged, as are a number of craniofacial abnormalities including a high palate, recessed chin, small jaw, low set ears and clinodactyly, a condition in which the pinky fingers are bent inward from the topmost knuckle. Additionally, her palms are crossed by a single crease, rather than 3, according to the lawsuit.
Subsequent tests have failed to detect a genetic anomaly, and Plaintiff claims her family has no history of birth defects. However, recent studies have linked the “off-label” use of Zofran in pregnancy to major heart defects and cleft palate. In 2013, a Danish research team found that babies exposed to Zofran in the womb are between 2 and 4 times more likely to be born with cardiac septal defects.
The complaint was originally filed in the U.S. District Court of New Jersey on March 15, 2016, but later transferred to the Zofran multidistrict litigation (MDL) in Boston, where nearly 300 similar cases have been consolidated for pretrial handling. The most recent filing represents an amended complaint, submitted to the U.S. District Court of Massachusetts on August 1, 2016
Do I Have a Zofran Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Zofran lawsuits. We are handling individual litigation nationwide and currently accepting new birth defects cases in all 50 states.
Free Confidential Case Evaluation: Again, if your child was injured by Zofran side effects, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.